Hans Jørn Kolmos

Hans Jørn Kolmos serves as a Clinical Professor at the University of Southern Denmark's Faculty of Health Sciences, affiliated with the Research Unit for Clinical Microbiology at Odense University Hospital (OUH). His work bridges clinical practice, academic research, and public health advocacy, with a focus on microbial pathogenesis and antibiotic resistance threats.

His research spans Clinical Microbiology and Infectious Diseases, specializing in bloodstream infections, Staphylococcus aureus epidemiology, and antimicrobial resistance mechanisms. He investigates intersections between infections and cardiovascular conditions like ischemic heart disease, while maintaining active virology interests including SARS-CoV-2 transmission dynamics. His fingerprint analysis reveals dominant work in Bloodstream Infection (100%), Staphylococcus Aureus (99%), and Methicillin-Resistant Staphylococcus Aureus (72%).

Recent publications reveal escalating focus on antibiotic resistance crises, including monographs and commentaries warning of post-antibiotic eras. His work combines laboratory research with policy advocacy, frequently addressing transmission pathways of resistant pathogens and zoonotic threats like mink-associated viruses. This aligns with his extensive media engagement (3,574 press mentions) on public health risks.

• DSKM's research award (2017)
• Knight of the Order of the Dannebrog (2014)
• Award for Civil Courage (2014)
• Faculty of Health Sciences Teaching Award (2002)

Kolmos supervises doctoral candidates (1 PhD completion documented) and actively participates in academic governance through committee memberships. His research unit drives clinical microbiology innovation while he maintains robust public engagement through lectures, media appearances, and policy interventions addressing antibiotic misuse and emerging pathogens.

He leads the Research Unit for Clinical Microbiology in Odense, collaborating extensively with Odense University Hospital and international networks. Current projects include probiotic cleaning applications, honey-based antimicrobials, and media literacy training for scientists, with scheduled 2025 activities addressing antimicrobial resistance futures.